pubmed-article:16299230 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16299230 | lifeskim:mentions | umls-concept:C0677886 | lld:lifeskim |
pubmed-article:16299230 | lifeskim:mentions | umls-concept:C0002844 | lld:lifeskim |
pubmed-article:16299230 | lifeskim:mentions | umls-concept:C0836924 | lld:lifeskim |
pubmed-article:16299230 | lifeskim:mentions | umls-concept:C0680727 | lld:lifeskim |
pubmed-article:16299230 | lifeskim:mentions | umls-concept:C1516164 | lld:lifeskim |
pubmed-article:16299230 | pubmed:issue | 22 | lld:pubmed |
pubmed-article:16299230 | pubmed:dateCreated | 2005-11-21 | lld:pubmed |
pubmed-article:16299230 | pubmed:abstractText | Preoperative thrombocytosis (platelet count > 400 x 10(9)/L) at initial exploration for epithelial ovarian carcinoma is associated with decreased surgical cytoreducibility and poor survival. Platelets express androgen receptor (AR), which contains a polymorphic CAG trinucleotide repeat sequence of which the length inversely correlates with AR transactivation function. We hypothesized that androgen-mediated thrombocytosis promotes aggressive ovarian cancer biology. | lld:pubmed |
pubmed-article:16299230 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16299230 | pubmed:language | eng | lld:pubmed |
pubmed-article:16299230 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16299230 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16299230 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16299230 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16299230 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16299230 | pubmed:month | Nov | lld:pubmed |
pubmed-article:16299230 | pubmed:issn | 1078-0432 | lld:pubmed |
pubmed-article:16299230 | pubmed:author | pubmed-author:LiAndrew... | lld:pubmed |
pubmed-article:16299230 | pubmed:author | pubmed-author:KarlanBeth... | lld:pubmed |
pubmed-article:16299230 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16299230 | pubmed:day | 15 | lld:pubmed |
pubmed-article:16299230 | pubmed:volume | 11 | lld:pubmed |
pubmed-article:16299230 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16299230 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16299230 | pubmed:pagination | 8015-8 | lld:pubmed |
pubmed-article:16299230 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:16299230 | pubmed:meshHeading | pubmed-meshheading:16299230... | lld:pubmed |
pubmed-article:16299230 | pubmed:meshHeading | pubmed-meshheading:16299230... | lld:pubmed |
pubmed-article:16299230 | pubmed:meshHeading | pubmed-meshheading:16299230... | lld:pubmed |
pubmed-article:16299230 | pubmed:meshHeading | pubmed-meshheading:16299230... | lld:pubmed |
pubmed-article:16299230 | pubmed:meshHeading | pubmed-meshheading:16299230... | lld:pubmed |
pubmed-article:16299230 | pubmed:meshHeading | pubmed-meshheading:16299230... | lld:pubmed |
pubmed-article:16299230 | pubmed:meshHeading | pubmed-meshheading:16299230... | lld:pubmed |
pubmed-article:16299230 | pubmed:meshHeading | pubmed-meshheading:16299230... | lld:pubmed |
pubmed-article:16299230 | pubmed:meshHeading | pubmed-meshheading:16299230... | lld:pubmed |
pubmed-article:16299230 | pubmed:meshHeading | pubmed-meshheading:16299230... | lld:pubmed |
pubmed-article:16299230 | pubmed:meshHeading | pubmed-meshheading:16299230... | lld:pubmed |
pubmed-article:16299230 | pubmed:meshHeading | pubmed-meshheading:16299230... | lld:pubmed |
pubmed-article:16299230 | pubmed:meshHeading | pubmed-meshheading:16299230... | lld:pubmed |
pubmed-article:16299230 | pubmed:meshHeading | pubmed-meshheading:16299230... | lld:pubmed |
pubmed-article:16299230 | pubmed:meshHeading | pubmed-meshheading:16299230... | lld:pubmed |
pubmed-article:16299230 | pubmed:meshHeading | pubmed-meshheading:16299230... | lld:pubmed |
pubmed-article:16299230 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:16299230 | pubmed:articleTitle | Androgen mediation of thrombocytosis in epithelial ovarian cancer biology. | lld:pubmed |
pubmed-article:16299230 | pubmed:affiliation | Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA. Andrew.Li@cshs.org | lld:pubmed |
pubmed-article:16299230 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16299230 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:16299230 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
entrez-gene:367 | entrezgene:pubmed | pubmed-article:16299230 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16299230 | lld:entrezgene |
lhgdn:association:34061 | lhgdn:found_in | pubmed-article:16299230 | lld:lhgdn |